AU9123201A - Novel polymorphic forms of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione maleate and process for their preparation - Google Patents
Novel polymorphic forms of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione maleate and process for their preparationInfo
- Publication number
- AU9123201A AU9123201A AU9123201A AU9123201A AU9123201A AU 9123201 A AU9123201 A AU 9123201A AU 9123201 A AU9123201 A AU 9123201A AU 9123201 A AU9123201 A AU 9123201A AU 9123201 A AU9123201 A AU 9123201A
- Authority
- AU
- Australia
- Prior art keywords
- thiazolidine
- pyridyl
- ethoxy
- benzyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN805CH2000 | 2000-09-26 | ||
PCT/US2001/029896 WO2002026737A1 (en) | 2000-09-26 | 2001-09-25 | Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU9123201A true AU9123201A (en) | 2002-04-08 |
Family
ID=29266775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU9123201A Pending AU9123201A (en) | 2000-09-26 | 2001-09-25 | Novel polymorphic forms of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione maleate and process for their preparation |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1322647A1 (en) |
JP (1) | JP2004509961A (en) |
AU (1) | AU9123201A (en) |
BR (1) | BR0114196A (en) |
CA (1) | CA2426117A1 (en) |
CZ (1) | CZ2003864A3 (en) |
HU (1) | HUP0301161A3 (en) |
IL (1) | IL155036A0 (en) |
MX (1) | MXPA03002580A (en) |
NO (1) | NO324968B1 (en) |
NZ (1) | NZ525498A (en) |
PL (1) | PL360661A1 (en) |
SK (1) | SK3752003A3 (en) |
WO (1) | WO2002026737A1 (en) |
ZA (1) | ZA200303223B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9726563D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
US6664278B2 (en) | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
UA67844C2 (en) | 1999-04-23 | 2004-07-15 | Смітклайн Бічам Плс | A polymorph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione of maleic acid salt |
SK286423B6 (en) | 1999-04-23 | 2008-09-05 | Smithkline Beecham Plc | Polymorphic form of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt, method for its preparation, pharmaceutical composition containing thereof and its use |
US20040248945A1 (en) | 1999-04-23 | 2004-12-09 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
WO2004062667A1 (en) * | 2003-01-08 | 2004-07-29 | Dr. Reddy's Laboratories Limited | Amorphous form of rosiglitazone maleate and process for preparation thereof |
GB0307259D0 (en) * | 2003-03-28 | 2003-05-07 | Glaxo Group Ltd | Process |
EP1468997A3 (en) * | 2003-04-18 | 2004-11-03 | CHEMI S.p.A. | Polymorphous forms of rosiglitazone maleate |
GB2405403A (en) | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
UA83504C2 (en) * | 2003-09-04 | 2008-07-25 | Селджин Корпорейшн | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
AR047541A1 (en) * | 2004-02-13 | 2006-01-25 | Sandoz Ag | PHOSPHATE OF 5 - [[4- [2-METHYL-2-PYRIDINYL-AMINO-ETOXI] PHENYL] METHYL] -2,4 THYZOLIDINADION (ROSIGLITAZONE) AND ITS POLYMORPHIC FORMS |
US20070225337A1 (en) * | 2004-03-31 | 2007-09-27 | Sandoz Ag | Novel Co-Precipitate of Amorphous Rosiglitazone |
JP2005350451A (en) * | 2004-05-11 | 2005-12-22 | Santen Pharmaceut Co Ltd | Agent for treating keratoconjunctival trouble |
WO2005108396A1 (en) * | 2004-05-11 | 2005-11-17 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for keratoconjunctiva disorder |
CZ2004844A3 (en) * | 2004-07-27 | 2006-03-15 | Zentiva, A. S | Salt of oxalic acid with 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, process for its preparation and its use |
ITMI20041537A1 (en) * | 2004-07-28 | 2004-10-28 | Chemi Spa | NEW POLYMORPHIC SHAPE OF EVIL ROSIGLITAZONE |
CZ298424B6 (en) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Crystallization process of rosiglitazone and derivatives thereof from mixed solutions |
EP2184055A1 (en) | 2008-11-07 | 2010-05-12 | LEK Pharmaceuticals d.d. | Process for preparing solid dosage forms of rosiglitazone maleate |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0842925A1 (en) * | 1987-09-04 | 1998-05-20 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
JP2000511875A (en) * | 1996-06-19 | 2000-09-12 | ドクター・レディーズ・リサーチ・ファウンデーション | Novel polymorphic forms of troglitazone with enhanced antidiabetic activity and methods for their production |
WO1997041120A1 (en) * | 1996-07-26 | 1997-11-06 | Dr. Reddy's Research Foundation | Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof |
GB9726566D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
UA67844C2 (en) * | 1999-04-23 | 2004-07-15 | Смітклайн Бічам Плс | A polymorph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione of maleic acid salt |
SK286423B6 (en) * | 1999-04-23 | 2008-09-05 | Smithkline Beecham Plc | Polymorphic form of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt, method for its preparation, pharmaceutical composition containing thereof and its use |
-
2001
- 2001-09-25 JP JP2002531121A patent/JP2004509961A/en active Pending
- 2001-09-25 CZ CZ2003864A patent/CZ2003864A3/en unknown
- 2001-09-25 WO PCT/US2001/029896 patent/WO2002026737A1/en active IP Right Grant
- 2001-09-25 AU AU9123201A patent/AU9123201A/en active Pending
- 2001-09-25 CA CA002426117A patent/CA2426117A1/en not_active Abandoned
- 2001-09-25 IL IL15503601A patent/IL155036A0/en unknown
- 2001-09-25 NZ NZ525498A patent/NZ525498A/en unknown
- 2001-09-25 BR BR0114196-1A patent/BR0114196A/en not_active Application Discontinuation
- 2001-09-25 HU HU0301161A patent/HUP0301161A3/en unknown
- 2001-09-25 SK SK375-2003A patent/SK3752003A3/en not_active Application Discontinuation
- 2001-09-25 PL PL01360661A patent/PL360661A1/en not_active Application Discontinuation
- 2001-09-25 MX MXPA03002580A patent/MXPA03002580A/en active IP Right Grant
- 2001-09-25 EP EP01971336A patent/EP1322647A1/en not_active Withdrawn
-
2003
- 2003-03-25 NO NO20031356A patent/NO324968B1/en unknown
- 2003-04-24 ZA ZA200303223A patent/ZA200303223B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200303223B (en) | 2004-07-26 |
JP2004509961A (en) | 2004-04-02 |
BR0114196A (en) | 2003-07-22 |
PL360661A1 (en) | 2004-09-20 |
CA2426117A1 (en) | 2002-04-04 |
WO2002026737A1 (en) | 2002-04-04 |
SK3752003A3 (en) | 2005-03-04 |
CZ2003864A3 (en) | 2004-01-14 |
NO20031356D0 (en) | 2003-03-25 |
MXPA03002580A (en) | 2003-10-15 |
WO2002026737A8 (en) | 2003-11-06 |
IL155036A0 (en) | 2003-10-31 |
NO20031356L (en) | 2003-05-26 |
NZ525498A (en) | 2004-11-26 |
EP1322647A1 (en) | 2003-07-02 |
NO324968B1 (en) | 2008-01-14 |
HUP0301161A3 (en) | 2005-04-28 |
HUP0301161A2 (en) | 2003-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU9123201A (en) | Novel polymorphic forms of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione maleate and process for their preparation | |
DZ3316A1 (en) | Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione | |
HK1045153A1 (en) | Polymorph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt | |
HUP0100509A3 (en) | 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical, process for its preparation and its pharmaceutical use | |
IL136381A (en) | Hydrate of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino) ethoxy] benzyl] thiazolidine-2,4-dione maleic acid salt, its preparation and pharmaceutical compositions comprising it | |
AU8428401A (en) | The hydrochloride salt of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione | |
IL188116A0 (en) | Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione | |
AU6255001A (en) | 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical | |
SI1265893T1 (en) | Hydrochloride salts of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione | |
SI1173435T1 (en) | Polymorph of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione maleic acid salt |